(CNN Español) – The assessors of the vacancies of the Administration of Medicines and Food of EE.UU. (FDA, by its seal in English) will vote the four to recommend that the agency issue an emergency use permit for the vaccine against the Johnson & Johnson coronavirus.
The Committee of Assessors of Vacancies and Biological Products Relacionados de la FDA (VRBPAC) agrees with a unanimous recommendation for the authorization of the vacuna en personas mayores of 18 years.
If the FDA accepts approval with the recommendation, and hopes that it will do so quickly, the vaccine will be converted into the authorized authorization for its use in EE.UU.
It will be the first vaccine of a single injection and one that can be dispensed with regular refrigerators, which facilitates the distribution of the Pfizer / BioNTech and Modern vaccines, which are more delicate and require dose.
The caravan, manufactured under the Johnson & Johnson, Janssen caravan framework, is being tested in more than 44,000 clinical clinics in EE.UU., South Africa and Latin America. ‘N Alledeagle Nivale, show a general efficiency of 66% in the prevention of moderate illnesses in graves. In the United States, it is effective at 72% and at 85% in graft prevention. Nadie who received the vaccine murmur by covid-19 during the trial.
Janssen’s vacancy is different from Pfizer’s and Modern’s vacancies, which are manufactured using a new technology that employs genetic material called ARN messenger ARNm. Janssen’s vaccine uses a common virus called adenovirus 26.
Although the Johnson & Johnson vacancy does not appear to have a 94% to 95% impact rate on Pfizer and Modern vacancies, investigators are urging the VRBPAC committee to try at a different time, with more circulating viruses and then new ones appearing variant. assured that it has the capacity to evade part of the immune response. Although no powder can demonstrate that these variants are responsible for the apparent minor efficacy of the Johnson & Johnson vaccine, the committee believes that powder has a factor.
If the FDA issues an emergency authorization, it can be produced as soon as possible at night. Depends on the Centers for Control and Prevention of Infants of EE.UU. (CDC por sig siglas en Engels) decidir si la vacuna realtee debe administrarse a los estadounidenses. The Assessment Committee for the Practice of Immunization (ACIP) of the CDC has scheduled a meeting for the domino to address the issue. The ACIP will vote on the domestic issue if the CDC approves the distribution of the vacancy and can also designate priority groups.
The director of the CDC, la Dra. Rochelle Walensky, there will be a final good show.
The federal government of the United States says that there is a list to distribute up to 4 million doses of the intermediate vaccine.